학술논문
Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) with or without Autologous Stem Cell Transplantation (ASCT) As First Line Treatment in Patients with Aggressive B-Cell Lymphoma with MYC and BCL-2 and/or BCL-6 Gene Rearrangements or Increase Copy Number
Document Type
Abstract
Author
Tucci, Alessandra ; Re, Alessandro ; Pagani, Chiara ; Guidetti, Anna; Dodero, Anna ; Marino, Fabrizio ; Casaroli, Ivana ; Soverini, Giulia ; Daffini, Rosa ; Balzarotti, Monica ; Campostrini, Giulia ; Lorenzi, Luisa ; Balzarini, Piera ; Facchetti, Fabio ; Carlo-Stella, Carmelo; Corradini, Paolo; Rossi, Giuseppe
Source
In Blood 5 November 2020 136 Supplement 1:38-39
Subject
Language
ISSN
0006-4971